183 related articles for article (PubMed ID: 8851029)
1. Immune tolerance to Factor VIII: the international registry data.
Mariani G; Hilgartner M; Thompson AR; Tusell J; Manco-Johnson M; Ghirardini A; Bellocco R; Brackmann HH
Adv Exp Med Biol; 1995; 386():201-8. PubMed ID: 8851029
[No Abstract] [Full Text] [Related]
2. Summary report of the First International Conference on inhibitors in haemophilia A.
Lacroix-Desmazes S; Scott DW; Goudemand J; Van Den Berg M; Makris M; Van Velzen AS; Santagostino E; Lillicrap D; Rosendaal FR; Hilger A; Sauna ZE; Oldenburg J; Mantovani L; Mancuso ME; Kessler C; Hay CRM; Knoebl P; Di Minno G; Hoots K; Bok A; Brooker M; Buoso E; Mannucci PM; Peyvandi F
Blood Transfus; 2017 Oct; 15(6):568-576. PubMed ID: 27893354
[No Abstract] [Full Text] [Related]
3. The incidence of inhibitors in hemophilia A and the induction of immune tolerance.
Briët E; Peters M
Adv Exp Med Biol; 2001; 489():89-97. PubMed ID: 11554594
[No Abstract] [Full Text] [Related]
4. Is oral tolerance therapy possible for haemophilia with inhibitors?
Terada K; Yagi Y; Niizuma T; Kataoka N
Vox Sang; 2001 Jan; 80(1):61-2. PubMed ID: 11339071
[No Abstract] [Full Text] [Related]
5. Immunetolerance as treatment of alloantibodies to factor VIII in hemophilia. The International Registry of Immunetolerance Protocols.
Mariani G; Scheibel E; Nogao T; Kasper CK; Ewing NP; Mauser-Bunschoten E; Ghirardini A; Bellocco R; Brackman HH
Semin Hematol; 1994 Apr; 31(2 Suppl 4):62-4. PubMed ID: 7939781
[No Abstract] [Full Text] [Related]
6. Prospective, observational study of plasma-derived factor VIII/von Willebrand factor in immune tolerance induction: the PRISM registry.
Kruse-Jarres R; Gilsenan A; Spears J; Kaye JA
Haemophilia; 2015 Mar; 21(2):e122-e124. PubMed ID: 25623889
[No Abstract] [Full Text] [Related]
7. Anti-factor VIII antibodies (Inhibitors) in hemophilia A: in dire need of basic and therapeutic research.
Kaveri SV
Clin Rev Allergy Immunol; 2009 Oct; 37(2):55-7. PubMed ID: 19153680
[No Abstract] [Full Text] [Related]
8. Adult haemophilia A patients with inhibitors: successful immune tolerance induction with a single FVIII/VWF product.
Rangarajan S; Jiménez-Yuste V; Santagostino E
Haemophilia; 2014 Nov; 20(6):e414-7. PubMed ID: 25333452
[No Abstract] [Full Text] [Related]
9. Immune tolerance in haemophilia and the treatment of haemophiliacs with an inhibitor. Proceedings of the 2nd Workshop on Immune Tolerance. Bonn-Konigswinter, Germany, August 27-30, 1997.
Vox Sang; 1999; 77 Suppl 1():1-100. PubMed ID: 10644229
[No Abstract] [Full Text] [Related]
10. [Hemophilia A with factor VIII inhibitor].
Shima M
Rinsho Ketsueki; 2003 Feb; 44(2):90-101. PubMed ID: 12692981
[No Abstract] [Full Text] [Related]
11. Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective.
White GC; Greenwood R; Escobar M; Frelinger JA
Haematologica; 2000 Oct; 85(10 Suppl):113-6. PubMed ID: 11187862
[TBL] [Abstract][Full Text] [Related]
12. [The young hemophiliac, inhibitors and immune tolerance].
Rothschild C
Transfus Clin Biol; 1999 Jun; 6(3):191-4. PubMed ID: 10422212
[TBL] [Abstract][Full Text] [Related]
13. Factor VIII inhibitors: risk factors and methods for prevention and immune modulation.
Zhang AH; Skupsky J; Scott DW
Clin Rev Allergy Immunol; 2009 Oct; 37(2):114-24. PubMed ID: 19199081
[TBL] [Abstract][Full Text] [Related]
14. Tolerance and intolerance to factor VIII: a clinical perspective.
Briët E
Adv Exp Med Biol; 1995; 386():193-9. PubMed ID: 8851028
[No Abstract] [Full Text] [Related]
15. Immune tolerance in hemophilia and treatment of hemophiliacs with an inhibitor.
Mariani G; Brackmann HH
Haematologica; 2001 Mar; 86(3):225-6. PubMed ID: 11255267
[No Abstract] [Full Text] [Related]
16. Antibodies to factor VIII in hemophilia A patients.
Brackmann HH; Schwaab R; Effenberger W; Hess L; Hanfland P; Oldenburg J
Vox Sang; 2000; 78 Suppl 2():187-90. PubMed ID: 10938950
[TBL] [Abstract][Full Text] [Related]
17. Alloantibodies to therapeutic factor VIII in hemophilia A: the role of von Willebrand factor in regulating factor VIII immunogenicity.
Oldenburg J; Lacroix-Desmazes S; Lillicrap D
Haematologica; 2015 Feb; 100(2):149-56. PubMed ID: 25638804
[TBL] [Abstract][Full Text] [Related]
18. Hemophilia.
Mariani G; Kroner BL; Brackmann HH
N Engl J Med; 2001 Oct; 345(14):1066; author reply 1067. PubMed ID: 11586969
[No Abstract] [Full Text] [Related]
19. Statistical modelling issues in the RODIN study.
Moorehead PC
Haemophilia; 2014 Jul; 20(4):e351-2. PubMed ID: 24827780
[No Abstract] [Full Text] [Related]
20. French previously untreated patients with severe hemophilia A after exposure to recombinant factor VIII : incidence of inhibitor and evaluation of immune tolerance.
Rothschild C; Laurian Y; Satre EP; Borel Derlon A; Chambost H; Moreau P; Goudemand J; Parquet A; Peynet J; Vicariot M; Beurrier P; Claeyssens S; Durin A; Faradji A; Fressinaud E; Gaillard S; Guérin V; Guérois C; Pernod G; Pouzol P; Schved JF; Gazengel C
Thromb Haemost; 1998 Nov; 80(5):779-83. PubMed ID: 9843171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
